Therefore, we surmise that the decrease of MHC expression in our present in vivo transplantation data is attributable to the low-level immune cell infiltration into tumors, which reduces total expression levels of MHC genes in tumors en bloc without affecting the expression of MHC genes in NRF2-activated 3LL cancer cells. This evidence concerns the gene NFE2L2 and cancer.